Lucid Diagnostics (LUCD) Change in Accured Expenses (2020 - 2026)
Lucid Diagnostics (LUCD) posted Change in Accured Expenses of -$519000.0 for Q1 2026, down 217.16% on a QoQ basis from $443000.0 in Q4 2025, and up 31.35% year-over-year from -$395129.9 in Q1 2025.
Lucid Diagnostics (LUCD) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Lucid Diagnostics' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$519000.0 for Q1 2026.
- Quarterly Change in Accured Expenses rose 31.35% year-over-year to -$519000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $127000.0 (down 87.61% YoY) and the FY2025 annual result came in at -$110000.0, up 89.13% from the prior year.
- Change in Accured Expenses was -$519000.0 for Q1 2026 at Lucid Diagnostics, down from $443000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $7.7 million in Q4 2022 and bottomed at -$3.5 million in Q3 2024.
- A 5-year average of $612411.8 and a median of $113000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses surged 2260.18% — and 2024, when it plunged 750.85%.
- Lucid Diagnostics' Change in Accured Expenses stood at $7.7 million in 2022, then sank by 112.36% to -$946000.0 in 2023, then soared by 480.44% to $3.6 million in 2024, then slumped by 87.69% to $443000.0 in 2025, then sank by 217.16% to -$519000.0 in 2026.
- Business Quant data shows LUCD's Change in Accured Expenses at -$519000.0 in Q1 2026, $443000.0 in Q4 2025, and -$569000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | -519,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -519,000.00 |
| Mar 31, 2026 | -519,000.00 |
| Dec 31, 2025 | 443,000.00 |
| Dec 31, 2025 | 443,000.00 |
| Sep 30, 2025 | -569,000.00 |
| Sep 30, 2025 | -569,000.00 |
| Jun 30, 2025 | 772,000.00 |
| Jun 30, 2025 | 772,000.00 |
| Mar 31, 2025 | -756,000.00 |
| Mar 31, 2025 | -756,000.00 |
| Dec 31, 2024 | 3.60 Mn |
| Dec 31, 2024 | 3.60 Mn |
| Sep 30, 2024 | -3.50 Mn |
| Sep 30, 2024 | -3.50 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | -2.79 Mn |
| Mar 31, 2024 | -2.79 Mn |
| Dec 31, 2023 | -946,000.00 |
| Dec 31, 2023 | -946,000.00 |